Risk Evaluation and Mitigation Strategies for US Drug Development, Second Edition

BooksBooks Member: $37.50 Nonmember: $62.50 APIsAudit/inspectionBiologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsComplianceDiagnostics/IVDsNorth AmericaNutritional/Natural HealthOTCOtherPharmaceuticalsRegulatory Intelligence/Policy